ASCO GU 2026: Updates in metastatic prostate cancer
Prof Gordon McVie provides highlights from ecancer for August 2016:
Video
The future of cancer prevention
Update on CaPP3 in high risk populations
Deciphering RAS/MAPK signalling in cancer
Journal
Negative trials in ovarian cancer: is there such a thing as too much optimism?
Complications from carcinoid syndrome: review of the current evidence
Role of nanotechnology and gene delivery systems in TRAIL based therapies
Education
ASCO GU 2026: Updates in metastatic prostate cancer
WCLC 2025: Latest in EGFR positive NSCLC
Transforming cancer care in India: The Access Cancer Care Initiative
Key insights from lung cancer research at ASCO 2025
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
GIST tumours and soft tissue sarcomas